Abiopharma

🔍 Stingi Richard John (Executive)

Company: BROADRIDGE FINANCIAL SOLUTIONS, INC. (BR)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Acquired 2,172 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,680.80 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a three-year performance period and represent a like number ofshares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on October 1, 2026.